These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29023843)

  • 41. Sustained wash-resistant receptor activation responses of GPR119 agonists.
    Hothersall JD; Bussey CE; Brown AJ; Scott JS; Dale I; Rawlins P
    Eur J Pharmacol; 2015 Sep; 762():430-42. PubMed ID: 26101059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonists.
    Dai X; Stamford A; Liu H; Neustadt B; Hao J; Kowalski T; Hawes B; Xu X; Baker H; O'Neill K; Woods M; Tang H; Greenlee W
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5291-4. PubMed ID: 26433449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design and synthesis of 1H-pyrazolo[3,4-c]pyridine derivatives as a novel structural class of potent GPR119 agonists.
    Matsuda D; Kobashi Y; Mikami A; Kawamura M; Shiozawa F; Kawabe K; Hamada M; Oda K; Nishimoto S; Kimura K; Miyoshi M; Takayama N; Kakinuma H; Ohtake N
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3441-6. PubMed ID: 27390068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity.
    Cornall LM; Hryciw DH; Mathai ML; McAinch AJ
    Mol Cell Endocrinol; 2015 Feb; 402():72-85. PubMed ID: 25578601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of a novel series of potent and orally bioavailable GPR119 agonists.
    Koshizawa T; Morimoto T; Watanabe G; Watanabe T; Yamasaki N; Sawada Y; Fukuda T; Okuda A; Shibuya K; Ohgiya T
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3249-3253. PubMed ID: 28648463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
    Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
    Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists.
    Yang Z; Fang Y; Pham TA; Lee J; Park H
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1519-21. PubMed ID: 23374864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion.
    Kogure R; Toyama K; Hiyamuta S; Kojima I; Takeda S
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):58-63. PubMed ID: 22079287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Gormley NM; Flatt PR
    Diabetologia; 2016 Dec; 59(12):2674-2685. PubMed ID: 27677765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimization of CHARMM force field parameters of a prostate cancer drug enzalutamide.
    Baday S
    J Mol Graph Model; 2020 May; 96():107541. PubMed ID: 31982813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GPR119 agonists for the treatment of type 2 diabetes.
    Jones RM; Leonard JN; Buzard DJ; Lehmann J
    Expert Opin Ther Pat; 2009 Oct; 19(10):1339-59. PubMed ID: 19780700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GPR119 agonists: a promising new approach for the treatment of type 2 diabetes and related metabolic disorders.
    Shah U
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):519-32. PubMed ID: 19562648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and synthesis of diazatricyclodecane agonists of the G-protein-coupled receptor 119.
    Darout E; Robinson RP; McClure KF; Corbett M; Li B; Shavnya A; Andrews MP; Jones CS; Li Q; Minich ML; Mascitti V; Guimarães CR; Munchhof MJ; Bahnck KB; Cai C; Price DA; Liras S; Bonin PD; Cornelius P; Wang R; Bagdasarian V; Sobota CP; Hornby S; Masterson VM; Joseph RM; Kalgutkar AS; Chen Y
    J Med Chem; 2013 Jan; 56(1):301-19. PubMed ID: 23234271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and SAR studies of bicyclic amine series GPR119 agonists.
    Sakairi M; Kogami M; Torii M; Kataoka H; Fujieda H; Makino M; Kataoka D; Okamoto R; Miyazawa T; Okabe M; Inoue M; Takahashi N; Harada S; Watanabe N
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5123-8. PubMed ID: 22765901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulating beta cell replication and improving islet graft function by GPR119 agonists.
    Gao J; Tian L; Weng G; Bhagroo NV; Sorenson RL; O'Brien TD; Luo J; Guo Z
    Transpl Int; 2011 Nov; 24(11):1124-34. PubMed ID: 21902730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [GPR119 Receptor Agonists: Characteristics, Physiological Role, Prospects of Use in the Treatment of Diabetes Mellitus Type 2 and Metabolic Syndrome].
    Tyurenkov IN; Kurkin DV; Bakulin DA; Lomkina EM; Volotova EV
    Usp Fiziol Nauk; 2015; 46(4):28-37. PubMed ID: 27183782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia.
    Li NX; Brown S; Kowalski T; Wu M; Yang L; Dai G; Petrov A; Ding Y; Dlugos T; Wood HB; Wang L; Erion M; Sherwin R; Kelley DE
    Diabetes; 2018 Jul; 67(7):1401-1413. PubMed ID: 29669745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The significance of GPR119 agonists as a future treatment for type 2 diabetes.
    Dhayal S; Morgan NG
    Drug News Perspect; 2010 Sep; 23(7):418-24. PubMed ID: 20862393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. YH18421, a novel GPR119 agonist exerts sustained glucose lowering and weight loss in diabetic mouse model.
    Park YH; Choi HH; Lee DH; Chung SY; Yang NY; Kim DH; Ju MK; Han TD; Nam SY; Kim KW
    Arch Pharm Res; 2017 Jun; 40(6):772-782. PubMed ID: 28593550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist.
    Yang Z; Fang Y; Park H
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2515-2519. PubMed ID: 28408218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.